Dr
AstraZeneca, United Kingdom
Senior scientist working across Cell Engineering, Cell Biology and Functional Genomics. Expertise in using CRISPR/Cas9 and NGS for target identification, target validation and drug development in the oncology disease area.
Has worked on a breadth of oncology projects, from the Target Selection stage to Candidate Drug. Also possesses experience of phenotypic screening in primary immune cells.
As well as genome editing, strong background in pancreatic cancer, DNA damage response and predictive biomarkers.